Firm News: Drugs & Devices: Page 12

W&L Accepting Zofran Birth Defect Claims

W&L is now accepting cases of congenital heart defects and cleft facial abnormalities in children whose mothers during pregnancy took the prescription drug Zofran to relieve the symptoms of morning sickness. Zofran — generic name ondansetron — has never been approved by the U.S. Food & Drug Administration (FDA) for treatment of morning sickness symptoms. Further, medical studies…

W&L Taking Zimmer Persona Knee Replacement Cases

Weitz & Luxenberg is now investigating cases in which patients suffered harm from use of a Zimmer Persona knee replacement device. The porous coated, uncemented Zimmer Persona Trabecular Metal Tibial Plate was voluntarily recalled on Feb. 16 and was categorized as a U.S. Food and Drug Administration (FDA) Class II recall on March 12. The…

Relkin to Speak at HarrisMartin’s MDL Conference

Ellen Relkin will be presenting on Xarelto Case Selection and Criteria at the upcoming HarrisMartin MDL Conference: Xarelto, Morcellators and Emerging Torts. She will discuss the criteria to consider for accepting cases, as well as the bases for pursuing this litigation against a manufacturer who has created a medication that puts patients at untoward risk…

W&L Investigates Duodenoscopes That May Cause Serious Infections

W&L today began investigating possible claims against the manufacturers of special types of duodenoscopes, known as ERCP duodenoscopes. News recently broke that the medical instruments are capable of harboring a potentially deadly strain of a rare antibiotic-resistant “superbug” bacteria, as well as other infections. This bacteria, which is known as carbapenem-resistent Enterobacteriaceae (CRE), is now…

Relkin Presents at NJICLE in N.J.

The New Jersey Institute for Continuing Legal Education (NJICLE) is hosting a book launch for their 2015 New Jersey Mass Torts & Class Action Treatise at their February 18 continuing legal education seminar. Ellen Relkin., a N.J. Certified Civil Trial Attorney with W&L, has contributed a chapter to the NJICLE publication. At the seminar, Multicounty (Mass Tort)…